Sinopharm: Chinese Covid vaccine gets WHO emergency approval
World 09:41 PM - 2021-05-07.
The World Health Organization (WHO) has granted emergency approval for the Covid vaccine made by Chinese company Sinopharm.
It is the first vaccine developed by a non-Western country to get WHO backing.
The vaccine has already been given to millions of people in China and elsewhere.
The WHO had previously only approved the vaccines made by Pfizer, AstraZeneca, Johnson & Johnson and Moderna.
But individual health regulators in various countries - especially poorer ones in Africa, Latin America and Asia - have approved Chinese jabs for emergency use.
With little data released internationally early on, the effectiveness of the various Chinese vaccines has long been uncertain.
But the WHO on Friday said it had validated the "safety, efficacy and quality" of the Sinopharm jab.
The WHO said the addition of the vaccine had "the potential to rapidly accelerate Covid-19 vaccine access for countries seeking to protect health workers and populations at risk".
It is recommending that the vaccine be administered in two doses to those aged 18 and over.
A decision is expected within days on another Chinese vaccine developed by Sinovac, while Russia's Sputnik vaccine is under assessment.
PUKmedia / BBC
More news
-
German Forces Commander Ended his Mission at Mam Jalal's Grave
12:28 PM - 2024-04-23 -
Golden Bla Awards Ceremony Takes Place in Sulaymaniyah
11:32 AM - 2024-04-23 -
PUK Official: PUK is Committed to Holding Elections on Time
11:04 AM - 2024-04-23 -
Turkish President Meets Kurdish Officials in Erbil
10:42 AM - 2024-04-23
see more
DPM Talabani Asks Turkish President to Lift Ban on Sulaymaniyah Airport
11:43 AM - 2024-04-23
Iraqi & Turkish Presidents: Problems Should Be Resolved Through Dialogue
05:00 PM - 2024-04-22
PUK President: We Will Protect Journalists' Rights
03:10 PM - 2024-04-22
DPM Talabani: We Will Defend Freedom of Press
10:26 AM - 2024-04-22
Most read
-
10 Notable Individuals Receive Golden Bla Award
Kurdistan 09:27 PM - 2024-04-23